Watermark
  Back to Search Results

AdvanTIG-206

Completed

A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

AdvanTIG-206

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04948697

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20211546

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan